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Objectives: Human leukocyte antigen (HLA)-B27 (B27) is the strongest genetic factor associated with
development of Ankylosing Spondylitis and other spondyloarthropathies (SpA), yet the role it plays in
disease pathogenesis remains unclear. We investigated the expression of potentially pathogenic non-
conventional heavy chain forms (NC) of B27 in synovial and intestinal tissues obtained from SpA pa-
tients. We also determined the presence of NC-B27 in joints, lymphoid and gastrointestinal tissue from
B27 transgenic (TG1) rats with M.tuberculosis-induced SpA.
Methods: Expression of NC-B27 in human SpA joints and gut and in (21-3  283-2)F1 HLA-B27/Hub2m
rat tissue was determined by immunohistochemistry, ﬂow cytometry and confocal microscopy analysis
using HC10 and HD6 antibodies.
Results: Both HC10- and HD6-reactive HLA molecules were present in synovial tissue from SpA patients.
Both NC-B27 and KIR3DL2, a ligand for NC-B27, were expressed in inﬂamed terminal ileal tissues in
patients with early SpA. Inﬁltrating cells in inﬂamed joint tissues isolated from B27 TG1 rats expressed
high levels of NC-B27. NC-B27 were also expressed in joint-resident cells from ankle and tail joints of B27
TG1 rats prior to clinical arthritis. The expression of NC-B27 on B27 TG1 rat CD11b/cþ, CD8aþ, cells from
spleens and LNs increased with animal age and disease progression.
Conclusions: Non-conventional HLA class 1 molecules are expressed on resident and inﬁltrating cells in
both synovial and GI tissues in human SpA. NC-B27 expression in joints and lymphoid tissues from B27
TG1 rats prior to the onset of arthritis is consistent with the hypothesis that they play a pathogenic role in
SpA.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The spondyloarthropathies (SpA) are a group of closely related
chronic inﬂammatory diseases that share genetic, clinical and
pathophysiological features. The very strong association of thee Institute of Musculoskeletal
entre, Windmill Road, Oxford
nik).
r Ltd. This is an open access articlehuman leukocyte antigen HLA-B27 (B27) with SpA was discovered
more than four decades ago, yet the role B27 plays in disease
pathogenesis remains unclear. We have previously described the
ability of HLA-B27 to form beta 2 microglobulin-free homodimers
[1]. These and other non-conventional forms of B27 (NC-B27),
including free heavy chain forms (FHC), can be expressed both
intracellularly [2], and at the cell surface [1,3]. Increased expression
of cell surface FHC has been demonstrated on SpA patient-derived
monocytes and peripheral blood mononuclear cells (PBMCs) [4e6].
Recent GWAS studies have identiﬁed IL23R and other genesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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in Ankylosing Spondylitis (AS) [7e11]. Furthermore, several clinical
and animal studies have suggested the importance of IL23R/IL-17
axis in pathogenesis of SpA, including AS and PsA [5,12e19]. We
have previously shown that cell surface-expressed NC-B27 can
interact with innate immune receptors including KIR3DL2
expressed on NK and CD4þ Tcells [20e24], and that this interaction
can drive Th17 immune responses [5,15].
These ﬁndings led us to ask two important questions: a) are
these NC-B27 forms expressed in the inﬂamed target tissues in
SpA? and b) is this expression a consequence of inﬂammation or
does it precede inﬂammation?
Here we describe expression of NC-B27 in joint and gut tissue in
both human SpA and in (21-3  283-2) F1 HLA-B27/Hub2m B27
transgenic rats including those with M. tuberculosis-induced
arthritis and spondylitis.
2. Materials and methods
2.1. Patients
Human synovial tissue samples were obtained with informed
consent and appropriate ethical permission, from 4 B27þ SpA pa-
tients, including 1 with Ankylosing Spondylitis (AS) fulﬁlling the
New York classiﬁcation criteria [25], and 10 patients with Rheu-
matoid Arthritis (RA) fulﬁlling the EULAR/ACR criteria [26].
Gastrointestinal tissue samples were obtained, with informed
consent and appropriate ethical permission, from 10 AS B27þ pa-
tients and 10 healthy B27 individuals undergoing ileocolonoscopy
for diagnostic purposes but without clinical evidence of underlying
disease.
2.2. Rat-derived cells and tissues
B27 transgenic (TG) rats ﬁrst generated by Hammer and col-
leagues spontaneously develop inﬂammatory gut and joint disease
[27], and express B27 homodimers on their dendritic cells [28], and
NC-B27 molecules on splenocytes [29]. However NC-B27 expres-
sion has not been studied using the more recent (21-3  283-2) F1
HLA-B27/Hub2m TG rat model, in which additional human b2m is
introduced. We hereafter term this model B27 TG1. A higher pro-
portion of these B27 TG1 male rats spontaneously develop arthritis
(~70%, 4e6months of age) and spondylitis (30e50%, 7e9months of
age) without symptoms of gut inﬂammation [30e32]. Early and
coordinated onset of these SpA-like disease manifestations can be
triggered by immunization with low doses of heat-inactivated
M. tuberculosis (hereafter referred to as “M.tb-induced arthritis
and spondylitis”) [33,34]. Splenocytes, lymph node cells (LNs),
ankle, tail joints and GI tissues were isolated from B27 TG1 rats with
spontaneous or induced SpA at age 4e15 weeks. For M.tb-induced
arthritis and spondylitis [33], 6 week-old B27 TG1 rats were
immunized with 30e45 mg of heat-inactivated M.tb in incomplete
Freund's adjuvant. (120-4  283-2)F1 HLA-B7/Hub2m TG (B7 TG)
and Lewis wild type (WT) animals ± 200 mg of heat-inactivatedM.tb
in IFA (adjuvant-induced arthritis, AIA model) were used as con-
trols. All animals were bred and housed at the animal facility of the
AMC, University of Amsterdam, Netherlands. All animal procedures
were carried out in compliance with Institutional Standards for
Human Care and Use of Laboratory Animals.
2.3. Antibodies
The HC10 antibody stains many or all heavy chain forms (but not
beta-2-microglobulin-associated conventional forms) of most hu-
man HLA-B and some HLA-A alleles, but does not cross react withrat MHC [35]. The HD6 antibody was raised against B27 homo-
dimers using a fully human FAb antibody library (kindly provided
by Dynax, MA, USA) as previously described [5], and is more spe-
ciﬁc for heavy chain forms of HLA-B27. HD6r (same speciﬁcity as
HD6 but with rat IgG1 Fc region) was used for some stains. The M-
K323-12B11, anti-KIR3DL2 mAb was a kind gift of Innate Pharma,
France. W6/32 and ME1 recognize beta-2 microglobulin-associated
class 1 molecules, as used in previous studies [29].
2.4. Immunohistochemistry of human and rat tissue samples
Human SpA and RA, and rat parafﬁn-embedded synovial tissue
samples were prepared as previously described [32,36,37].
Parafﬁn-embedded tissue sections were blocked using Peroxidase
Blocking Reagent (EnVision™, Dako), than incubated with PBS/1%
FBS/10% goat serum and subsequently stained overnight with HC10
or HD6 primary mAb. HC10-stained sections were incubated with
HRP-labeled anti-mouse IgG (EnVision™, Dako). HD6-stained sec-
tions were incubated with biotinylated goat anti-mouse IgG1
(Southern Biotech) followed by streptavidin-HRP (Dako). Tissue
sections were than incubated with AECþ substrate-chromogen
(EnVision™, Dako) and counterstained using Mayer's hematoxy-
lin. Slides were visualized and scanned using AperioCS2 Scanner
and analyzed using Aperio ImageScope software (Leica Biosystems,
UK).
Frozen GI tissue sections from B27þ AS patients and healthy
controls were blocked before incubation with primary antibodies:
HD6r, M-K323-12B11 or isotype control. Tissues were next incu-
bated with biotinylated secondary antibody followed by incubation
with streptavidin-HRP, then developed with diaminobenzidine and
counterstained with hematoxylin. The number of positive cells was
determined by evaluating reactive cells onmicrophotographs taken
from three randomly selected high-power microscopic ﬁelds under
a Leica DM2000 optical microscope.
Double staining for HD6r and CD3 or CD68 were performed on
frozen ileal sections. Sections were treated with FITC-, RR- or Cy-5-
conjugated anti-mouse or anti-rabbit antibodies (Invitrogen) plus
RNase and counterstained using DAPI (Life Technologies). Antibody
staining was analyzed by immunoﬂuorescence confocal
microscopy.
2.5. Flow cytometry
Splenocytes and LNs were freshly isolated and immediately
stained as described previously [29]. Cells were incubated in
blocking buffer, and then stained with primary antibody (HC10,
HD6, ME1 or IgG1/IgG2a), followed by incubation with secondary
goat anti-mouse antibody (Alexa Fluor 647, Invitrogen). Subse-
quently, cells were stained for the phenotypic surface markers: CD4
and CD8a or CD45R and MHCII, or CD11b/c. Dead cells were
excluded using ﬁxable viability dye eFluor®780 (eBioscience). Flow
cytometric analysis was performed with BD FACS Canto and data
were analyzed using FlowJo Software (TreeStar). Staining was
performed in triplicates. Error bars were calculated based on SD
mean of the values if 3  animals per group. P values were deter-
mined using nonparametric Mann-Whitney test.
3. Results
3.1. Non-conventional HLA class I molecules are detected on
synovial cells in the intimal and sublining layers in B27þ SpA, but
not in RA tissues
We ﬁrst wished to determine whether non-conventional HLA I
molecules were expressed in the inﬂamed peripheral joints from
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intimal and sublining layer cells in synovial tissues from B27þ SpA
but not RA patients. HC10 staining was also detected on mono-
nuclear cells found in lymphoid follicles in synovial tissue in both
SpA and RA (Fig. 1, C and F). Of note we observed similar patterns of
HC10 and HD6 staining in both frozen and parafﬁn-ﬁxed synovial
SpA tissues (see Fig. 1 in Ref. [38]). HD6 staining was detected in
intimal and sublining layers and on cells in the lymphoid follicles in
parafﬁn-embedded tissues from SpA patients, although back-
ground staining on both SpA and RA synovial tissues was seen (see
Fig. 1 in Ref. [38] and data not shown). Due to the tissue preparation
and IHC staining procedures used in this study, we did not observe
staining with ME1 and W6/32 antibodies (data not shown).
3.2. Gut tissue cells from HLA-B27-positive AS patients express both
higher levels of non-conventional HLA class I molecules and the
natural killer receptor KIR3DL2
To extend our ﬁnding that non-conventional class 1 molecules
are expressed in synovial tissue, we next looked for expression in
another target tissue in SpA, the gut mucosa. We used the HD6rFig. 1. HC10-expressing cells are present in the intimal and sublining layers of synovi
parafﬁn-embedded synovial tissue sections from inﬂamed B27þ AS patient peripheral join
lymphoid cell inﬁltrates/follicles (10X). (DeF) HC10 staining in inﬂamed synovial tissue fro
follicles, but is absent in the intimal and sublining layers of synovial tissue: (D) 0.3X, (E) ce
inﬁltrates/follicles (10X). All images were captured at 20X objective lens using AperioSca
patients.mAb to determine whether NC-B27 molecules are present in hu-
man (GI) tissues from B27þ AS patients with subclinical inﬂam-
mation. HD6 staining was observed in GI tissue sections from B27þ
AS patients independently of the degree of gut inﬂammation, but
not in tissues from B27 healthy controls (Fig. 2, A vs B). The ma-
jority of HD6 staining was present on inﬁltrating mononuclear cells
in the lamina propria. Further immunoﬂuorescence analysis of
frozen sections showed that HD6 staining was seen on both CD3þ
and CD68þ cells (Fig. 2, CeF). We also studied mononuclear cell
expression of the natural killer receptor KIR3DL2, which strongly
binds NC-B27 [20]. Fig. 2G shows the presence of abundant
mononuclear cells expressing KIR3DL2 in ileal tissue from a B27þ
AS patient. This was not seen in healthy control tissue (Fig. 2H).
Thus both NC-B27 and KIR3DL2, a key ligand for NC-B27, are
expressed in GI tissue from AS patients with subclinical
inﬂammation.al tissue from B27þ AS patients but not from RA patients. (AeC) HC10 staining in
t: (A) 0.7X, (B) HC10 þ ve cells in the synovial tissue intimal and sublining (8X), (C)
m RA patient with peripheral arthritis is present only on cell inﬁltrates in lymphoid
lls in the synovial tissue intimal and sublining (8X), (F) HC10 staining in lymphoid cell
nner and analyzed in ImageScope. Representative of 4 B27þ SpA patients and 10 RA
Fig. 2. HD6þ and KIR3DL2þ cells are present in B27þ AS gastrointestinal tissue. (A, B) HD6(r) staining of frozen gastrointestinal tissue sections from (A) a B27þ AS patient
(n ¼ 10) and (B) a healthy B27 control (n ¼ 10). (C, D) Immunoﬂuorescence double staining of frozen gastrointestinal tissue with (C) HD6r (red) and CD3 (green), or (D) HD6r (red)
and CD68 (green) from a B27þ AS patient. Nuclear staining DAPI (blue). (E, F) quantiﬁcation of (E) HD6rþ/CD3þ and (F) HD6rþ/CD3þ double positive cells in frozen gastrointestinal
tissue from B27þ AS patient. (G, H) anti-KIR3DL2(M-K323-12B11, Innate Pharma, France) staining of frozen gastrointestinal tissue sections from (G) a B27þ AS patient and (H) a
healthy B27 control. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. HC10 staining is present on cells in the synovium and at bone remodeling sites in inﬂamed ankle joints from B27 TG1 but not control Lewis rats. (AeD) HC10 staining
in parafﬁn-embedded ankle joint from M.tb-induced SpA: (A) 0.6X; (B) 4X; (C) 20X view of intimal and sublining layers of the synovial tissue; D) 20X view showing staining of
mononuclear cells and multinucleated osteoclast-like cells (arrows) in bone remodeling sites. (EeH) HC10 staining of healthy control Lewis WT rat ankle joint: (E) 0.5X; (F) bone and
chondrocyte cartilage sites (5X); (G) bone and attached synovial and adipose tissue (6X); (H) synovial tissue in the muscle attachment area (10X). All images were captured at 20X
objective lens using AperioScanner and analyzed in ImageScope. Representative of 5 animals.
O. Rysnik et al. / Journal of Autoimmunity 70 (2016) 12e21163.3. NC-B27 molecules are highly expressed on cells in the
synovium, at bone remodeling sites in inﬂamed joints and in the gut
of B27 TG1 rats with M.tb-induced arthritis and spondylitis
We next asked if NC forms are expressed in the joints of B27
transgenic ratswith arthritis and spondylitis. Fig. 3 showsmarkedly
increased expression of NC-B27 in inﬂamed ankle joints from B27
TG1 rats (12e15 weeks old) with M.tb-induced arthritis and spon-
dylitis (compared with Lewis WT rats). HC10 staining was present
on inﬁltrating mononuclear cells (Fig. 3B), on mononuclear cells in
the intimal and sublining layers of synovial tissue (Fig. 3C), and oncells at bone remodeling sites (Fig. 3D). HC10 staining was also
observed on multinucleated (osteoclast-like) cells at bone remod-
eling sites and on bone marrow mononuclear and multinuclear
cells (Fig. 3D arrows). Comparable HC10 staining was observed in
axial joints from B27 TG1 rats with M.tb-induced SpA, particularly
in cell inﬁltrates at the junction between the vertebrae, connective
tissue and annulus ﬁbrosus (see Fig. 2 in Ref. [38]). We did not
observe HC10 staining in ankle or tail joints from healthy Lewis WT
rats (Fig. 3E-H and Fig. 2E and F in Ref. [38]), or in ankle joints from
Lewis WT rats with adjuvant-induced arthritis (AIA) (see Fig. 3 in
Ref. [38]).
Fig. 4. HD6 staining is present on cells in the synovium, at bone remodeling sites and in the bone marrow in ankle joints from B27 TG1 but not control Lewis rats. (AeD) HD6
staining in parafﬁn-embedded ankle joint tissue section from diseased B27 TG1 rat. (A) 0.6X; (B) 10X; (C) increased HD6 staining on multinucleated osteoclast-like cells in bone
remodeling site (20X); (D) HC10þ cells in bone marrow (20X). (EeH) HD6 staining was not detected in control Lewis WT rats with no disease: (E) 0.6X; F) and (G) bone and
chondrocyte cartilage sites with surrounding synovium (5X and 10X); (H) bone and connective and adipose tissue near the bone area. All images were captured at 20X objective lens
using AperioScanner and analyzed in ImageScope. Representative of 5 animals.
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B27 TG1 rats with M.tb-induced arthritis and spondylitis, using the
HD6mAb generated against B27 homodimers [5,39],. As with HC10,
HD6 staining was observed on inﬁltrating mononuclear cells in
ankle joints (Fig. 4A and B), and on mononuclear cells at bone
remodeling sites (Fig. 4C). Notably, multinucleated osteoclast-like
cells present at bone remodeling sites (Fig. 4C, arrows) and
mononuclear cells in bone marrow (Fig. 4D, arrows) stained
strongly with HD6. Similar HD6 staining was observed in axial
joints (Data not shown). No HD6 staining was seen for ankle (Fig.
4EeH) or tail joints from healthy Lewis WT animals (Data not
shown) or for ankle joints from Lewis WT animals with AIA (see
Fig. 3EeH in Ref. [38]). Tissue sections from B27 TG1 rats withM.tb-
induced arthritis and spondylitis did not stain with IgG1 isotype
control (see Fig. 4 in Ref. [38]). Thus these data show that NC-B27forms are expressed in the inﬂamed joints of rats with arthritis
and spondylitis.
Since B27 transgenic rats [27] develop both gut and joint
inﬂammation, we next looked for evidence of NC-B27 expression in
gut tissues from B27 TG1 rats and control B7 TG and Lewis WT rats.
HC10 staining was detectable on mononuclear cells in small in-
testinal Peyer's patches, in lymphoid follicles and in the lamina
propria of all transgenic animals. Staining levels were higher for
B27 TG1 rats withM.tb-induced arthritis and spondylitis compared
to those without M.tb or healthy B7 TG animals (see Fig. 5 in Ref.
[38]). Speciﬁc HC10 staining was also seen in the colon (see Fig. 6 in
Ref. [38]). HD6 stained small and large bowel tissues of B27 TG1 rats
with M.tb-induced arthritis and spondylitis (see Fig. 7 in Ref. [38]).
Thus NC-B27 are expressed in gut tissue in B27 TG1 rats.
Fig. 5. NC-B27 expression on CD8aþ and CD11b/cþ cells from B27 TG1 rats increases with disease onset and is detectable in joints before clinical manifestations of arthritis.
(A) HC10 staining and (B) HD6 staining on CD11b/cþ, CD8aþ and CD4þ splenic cells isolated from B27 TG1 rats; spontaneous model (4 wo, open squares, n ¼ 2 and 11-15wo, closed
squares, n ¼ 5), and M.tb-induced rats (11e15 wo, closed diamonds, n ¼ 5). B7 TG (11 wo, closed circles, n ¼ 3) and Lewis WT (12e14 wo, open circles, n ¼ 5) rat splenocytes were
used as controls. Staining was performed in triplicates. Error bars were calculated based on SD mean of the values if 3 animals per group. P values were determined using
nonparametric Mann-Whitney test HC10 staining of ankle joints from (C, D) 12 wo B27 TG1 animals (spontaneous model) prior to disease onset and (E, F) healthy ankle joints from
aged matched Lewis WT rats. IHC staining is a representative of 5 animals.
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rats increases with disease onset. NC-B27 expression can be detected
in rat joints at a stage preceding overt arthritis
We also studied expression of NC-B27 in spleens and lymph
nodes taken from B27 TG1 animals prior to disease onset (sponta-
neous model) and from animals with M.tb-induced arthritis and
spondylitis. Expression of both HC10- and HD6-reactive molecules
was signiﬁcantly higher on splenic CD11b/cþ monocytic cells
(monocytes, dendritic cells or macrophages) (Fig. 5A, left) and
splenic CD8aþ cells (Fig. 5A, right) from the M.tb-induced animals
compared with age-matched B27 TG1 (spontaneous model). CD4þ
cells (Fig. 5A, right) also stained with HC10 and HD6, however the
intensity of staining was lower compared with CD8aþ and CD11b/
cþ cells. We did not observe any signiﬁcant difference in the
staining between age-matched B27 TG1 animals with and without
clinical symptoms. CD45þ/MHCIIþ cells expressed very low levels
of NC-B27 molecules (see Fig. 8 in Ref. [38]). Similar results were
observed with cells isolated from B27 TG1 lymph nodes ±M.tb (see
Fig. 9A in Ref. [38]), excepting that the CD11b/cþ cell population
was absent (see Fig. 5 and 10J in Ref. [38]). We also investigated
HC10 and HD6 staining of splenocytes taken from 8 to 9 weeks old
B27 TG1 animals with and without M.tb-induced SpA before the
appearance of clinical manifestations. HC10 was not signiﬁcantly
altered in splenic CD11b/cþ, CD8aþ or CD4þ cells, or on cell pop-
ulations from LNs (see Fig. 9BeD in Ref. [38]). However, we
observed an increase in HD6 staining on splenic CD4þ cells after
M.tb treatment (see Fig. 9C in Ref. [38]). No HC10 or HD6 staining
was observed in splenic and LN cells from age-matched Lewis WT
rats (data not shown). Splenic and LN cells from age-matched B7 TG
rats stained with HC10, but not HD6, to a similar degree compared
with B27 TG1 animals (spontaneous model) (Fig. 5A and B and see
Fig. 9A in Ref. [38]).
Lastly we asked if NC-B27 expression precedes or is a conse-
quence of inﬂammation? Fig. 5CeF shows that HC10 staining could
be detected in the joints of B27 TG rats at 12 weeks, sacriﬁced
shortly before the expected onset of overt arthritis. These data
indicate that increased NC-B27 expression precedes the onset of
clinical inﬂammation in B27 TG1 rats.
4. Discussion
Here we show that NC-B27 molecules are expressed in the
synovium and small bowel of B27þ SpA patients and in the joints,
gut tissues and lymphoid organs of B27 TG1 rats withM.tb-induced
arthritis and spondylitis. We observed HC10 staining of intimal and
sublining layers of synovial tissue from both human SpA patients
and B27 TG1 rats, as well as of inﬂammatory cell inﬁltrates/
lymphoid follicles. Whilst HC10 staining was also observed in sy-
novial tissue from RA patients, staining of synovial intimal and
sublining layers was speciﬁc to B27þ SpA patients. Our data suggest
that resident or inﬁltrating cells in the intimal and sublining layers
of the synovium could play a role in the arthritis of SpA patients.
These cells include T cells and macrophages [40]. Of note in the GI
tissue sections from B27þ AS patients both CD3þ cells (which could
be TCR gd or ab cells) and CD68þ cells stained with HD6. Although
B27 TG1 rats do not develop gastrointestinal inﬂammation, we
observed increased intensity of HC10 staining in GI tissues from
B27 TG1 rats with axial and peripheral arthritis compared with
animals before the onset of clinical manifestations. However, it is
yet unclear whether the changes in the expression of NC-B27 in rat
GI tissues are a cause or a consequence of joint inﬂammation. The
effects of diet and microbiome on NC-B27 expression may be also
be signiﬁcant and undoubtedly also merit detailed investigation.
NC-B27 molecules were expressed by cells in ankle and axialjoints and in peripheral lymphoid organs from B27 TG1 animals.
NC-B27 expression was also detected in the joints of unimmunized
animals shortly before the expected onset of arthritis. We also
observed signiﬁcant increases in NC-B27 expression on different
leukocyte populations with increasing age in (21-3  283-2) F1
(B27 TG1) animals (±M.tb). Similar changes have been reported in
an earlier B27 TG rat model, in which animals develop severe
gastrointestinal inﬂammation but arthritis is present at lower fre-
quency [29]. Treatment of these B27 TG rats with a novel antibody
to B27 dimers (HD5) has recently been shown to reduce cell surface
B27 dimer expression, to reduce numbers of TNF- and IL-17-
producing CD4 T cells, and to enhance weight gain [19], lending
support to a pathological role for NC-B27.
Here we measured NC-B27 expression using two monoclonal
antibodies with overlapping speciﬁcities, HC10 and HD6. HC10
recognizes b2m-free heavy chain forms of most HLA-B and some
HLA-C alleles [35]. HD6 has a greater speciﬁcity for B27 homo-
dimers [5,39]. Both HC10- and HD6-reactive forms of NC-B27 have
been shown to bind to the killer immunoglobulin-like receptor
KIR3DL2 [20,23]. Binding of NC-B27 to KIR3DL2 promotes the
expansion of NK and T cells [15,20,41]. Cell surface HC10-reactive
molecules are found on all cell types expressing HLA class I. Our
ﬁndings, consistent with several other studies, suggest that their
expression in SpA-like disease is increased [4,6,42,43]. Due to the
tissue preparation and IHC staining procedures used in this study,
we did not observe any staining with ME1 and W6/32 antibodies.
We also cannot be certain to what extent observed NC-B27 staining
is located at the cell surface. Whilst it is possible that some NC-B27
staining results from sample preparation, we observed similar
patterns of HC10 and HD6 staining on frozen (as compared to
parafﬁn-ﬁxed) synovial SpA tissues, indicating that a signiﬁcant
proportion of NC-B27 are present at the cell surface.
Although expression of the KIR3DL2 receptor has been shown
previously on synovial NK and T cells, here we show for the ﬁrst
time KIR3DL2 expression in the gut of AS patients. Although the
present study lacks mechanistic work from human tissue, we have
previously shown that NC-B27 interactions with KIR3DL2
expressed on CD4þ Tcells promote Th17 immune responses in vitro
[15]. Notably, increased Th17 responses have been observed in B27
TG rats, with reduction by an antibody to NC-B27, suggesting
similar pathogenesis [19].
Based upon our ﬁndings we propose a model in which cell
surface expression of NC-B27 is a key factor in initiating or more
likely exacerbating joint and gut inﬂammation in SpA. Our data do
not conclusively differentiate between expression by resident cells
and inﬁltrating cells, although one possibility is that M.tb may
accelerate the progression of arthritis and spondylitis in B27 TG1
rats - via the activation and/or recruitment of cell populations
inﬁltrating the axial and peripheral joints. Direct interaction of
these mononuclear cells with NC-B27-expressing cells present in
joints may then exacerbate immune responses. Our results are also
consistent with models inwhich intracellular expression of NC-B27
in gut or joint cells initiates inﬂammation through ER stress or
autophagy [2], or depletion of together with dendritic cell abnor-
malities [44], as intra-cellular and cell surface NC-B27 expression
can occur together [3,45]. Notably aberrant class 1 expression may
also drive inﬂammation in related diseases including psoriasis and
Behcet's disease, and this has led to the concept of “MHC-I-opa-
thies” [46].
In conclusion, data presented in this paper show that NC-B27
molecules are expressed in the joints and gastrointestinal tract in
both human SpA and in the (21-3  283-2) F1 (B27 TG1) rat model
of human SpA. These ﬁndings are consistent with the hypothesis
that expression of non-conventional forms of B27 may amplify
immune-mediated inﬂammation.
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